Difference between revisions of "Ajay Kakkar"
Josh Leeson (talk | contribs) |
|||
| (One intermediate revision by one other user not shown) | |||
| Line 12: | Line 12: | ||
*Chair, [[House of Lords Appointments Commission]] | *Chair, [[House of Lords Appointments Commission]] | ||
*Adviser, [[Health Authority Abu Dhabi]]<ref> [http://www.parliament.uk/biographies/lords/lord-kakkar/3766 Lord Kakkar] ''Parliament.UK'', accessed 14 January 2015 </ref> | *Adviser, [[Health Authority Abu Dhabi]]<ref> [http://www.parliament.uk/biographies/lords/lord-kakkar/3766 Lord Kakkar] ''Parliament.UK'', accessed 14 January 2015 </ref> | ||
| − | + | *[[UAE-UK Business Council]] | |
==Notes== | ==Notes== | ||
<references/> | <references/> | ||
| − | [[Category:House of Lords|Kakkar, Ajay]][[Category:Revolving Door|Kakkar, Ajay]][[ | + | [[Category:House of Lords|Kakkar, Ajay]][[Category:Revolving Door|Kakkar, Ajay]][[Category:Healthcare Industry people|Kakkar, Ajay]] |
Latest revision as of 07:51, 4 April 2018
|
This article is part of the Revolving Door project of Spinwatch. |
Ajay Kakkar (Lord Kakkar) is a crossbench peer in the House of Lords, having joined on the 22 March 2010.
Interests
- Chairman, University College London Partners Limited
- Practising Surgeon
- Professor of Surgery, University College London
- Consultant Surgeon, University College London Hospitals NHS Foundation Trust
- Director, Thrombosis Research Institute, London
- Occasional scientific advisory and consultancy work, and honoraria, in the field of thrombosis research from: Bayer Healthcare; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Pfizer Inc; Sanofi;
- Member, General Medical Council
- Chair, House of Lords Appointments Commission
- Adviser, Health Authority Abu Dhabi[1]
- UAE-UK Business Council
Notes
- ↑ Lord Kakkar Parliament.UK, accessed 14 January 2015
